In 2020, Nanodigmbio Technology rejected the acquisition and relied on self-developed products to open up industry channels and stay at the forefront of the industry On November 26, 2021, Nanodigmbio s new oligonucleotide manufacturing facility

KAEDI BioMed Co , Ltd is a high-tech enterprise that integrates scientific research, NGS clinical diagnosis, CAR-T R & D and medical services